Vertex Pharmaceuticals | Jelenlegi Eszközök



Current Assets változás Dátum
AbbVie USD 25.58B 2.2B 2024-12
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
Agios Pharmaceuticals USD 965.6M 108.59M 2024-12
Alnylam Pharmaceuticals USD 3.3B 60.14M 2024-12
Amgen USD 29.03B 2.26B 2024-12
Arrowhead Research USD 570.54M 124.93M 2024-12
Biogen USD 7.46B 626.3M 2024-12
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Bristol-Myers Squibb USD 29.78B 1.7B 2024-12
Gilead Sciences USD 19.17B 4.39B 2024-12
Incyte USD 3.24B 430.32M 2024-12
Insmed USD 1.62B 28.18M 2024-12
Ionis Pharmaceuticals USD 2.62B 93.56M 2024-12
J&J USD 55.89B 2.64B 2024-12
Merck USD 38.78B 1.58B 2024-12
Moderna USD 8.1B 1.57B 2024-12
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
PTC Therapeutics USD 1.37B 83.98M 2024-12
Regeneron Pharmaceuticals USD 27.21B 7.88B 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 30.08B 589M 2024-06
Sarepta Therapeutics USD 3.07B 388.09M 2024-12
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
United Therapeutics USD 3.87B 126.5M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



Vertex Pharmaceuticals Jelenlegi Eszközök - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2025.